We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.

February has already been very busy across regulation, clinical research and community awareness - and we're only half way through! See below a round-up of the main breakthroughs and what to look out for during the rest of the month. ...

As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchONCOLOGY. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the oncology community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.

Whether you’re working in an agency, in a clinical role, or in academia, many healthcare professionals wonder what lies behind the doors of the pharmaceutical industry. In this episode, Gina is joined by Sian Kneller, Director of Global Content Design at GSK and Founder of The Agency Advantage, to unpack exactly what it takes to make the leap. With over 20 years’ experience, from medical writer to leading global medical affairs strategy, Sian now helps others make a successful move into pharma. In this episode she shares what the transition really looks like, which transferable skills matter most, and how you can stand out in a competitive field.

Dr Petros Grivas discusses how the neoadjuvant and perioperative landscape for bladder cancer is rapidly evolving. From durvalumab-based combinations for cisplatin-eligible patients to pembrolizumab–enfortumab vedotin for those ineligible for platinum therapy, the field is shifting fast. Dr Grivas shares key trial updates from ESMO25, emerging biomarker insights and a glimpse into the future of personalized and bladder-preserving treatment.

Cancer nursing is central to delivering complex, evidence-based cancer care across Europe. To meet evolving needs, the EONS Education Working Group develops frameworks, training, networks, and safety initiatives. These efforts advance professional growth, strengthen education, and shape the future of cancer nursing—ultimately improving outcomes for patients and families.

Every year, the World Bladder Cancer Patient Coalition convenes the only global gathering led by and for the bladder cancer patient community. The World Bladder Cancer Patient Forum takes place in Brussels, Belgium, on 13–14 October 2025 and you are invited to take part in this unique exchange.

In an evolving cancer landscape, cancer nurses are innovative leaders in cancer research. Their unique position at the intersection of clinical care and patient advocacy equips them to drive meaningful advancements in many critical areas, particularly symptom science.

As SIOG celebrates its 25th anniversary, Prof. Dr. Lore Decoster highlights how this year’s meeting in Ghent will focus on translating research into better daily care for older adults with cancer. With global care models, tumor-specific insights, and a strong call for collaboration, it promises to be a pivotal event.